WHAM
PRAX icon

Windmill Hill Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Windmill Hill Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,268
Closed -$218K – 29
2024
Q2 		$218K Hold
5,268
– – 0.09% 26
2024
Q1 		$321K Buy
+5,268
New +$236K 0.12% 26

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Windmill Hill Asset Management's PRAX Position: Q3 2024 in Review

Windmill Hill Asset Management sold out of Praxis Precision Medicines (PRAX) in Q3 2024, closing a stake of 5,268 shares — an estimated $218K sold.

Windmill Hill Asset Management first reported a position in PRAX in Q1 2024 and held it in 2 quarters. The position peaked at $321K in Q1 2024. 134 funds tracked by Wall St. Rank hold PRAX as of Q3 2024.

  • Windmill Hill Asset Management reported no remaining Praxis Precision Medicines position as of Q3 2024 after selling out during the quarter.
  • Windmill Hill Asset Management sold 5,268 Praxis Precision Medicines shares in Q3 2024, an estimated $218K.
  • Windmill Hill Asset Management first reported a position in Praxis Precision Medicines in Q1 2024 and held it in 2 quarters.
  • Windmill Hill Asset Management's Praxis Precision Medicines position peaked at $321K in Q1 2024.
  • 134 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2024.

Based on Windmill Hill Asset Management's 13F filing for Q3 2024, filed 15 Oct 2024.